Yaz and Yasmin News
Hillary Clinton’s blood clot opens dialogue about deep vein thrombosis
Blood clots have been cast center stage after former Secretary of State Hillary Clinton was hospitalized and treated for a clot that formed near her brain. The incident has led to in-depth media coverage of deep vein thrombosis and deadly blood clots that can form both in the brain and leg. More »
Birth control blood clot risk elevated in women with hormone disorder
Women with a hormone disorder called polycystic ovary syndrome (PCOS) who take birth control pills are at an increased risk of blood clots, according to a new study. Women with PCOS who used artificial hormone birth control pills such as Yaz or Yasmin were more than twice as likely to suffer a potentially deadly blood clot than women without PCOS taking birth control pills. More »
FDA-funded study finds increased risk of blood clots among birth control users
A study funded by the Food and Drug Administration (FDA) and led by the Kaiser Foundation has found that women who use birth control containing the artificial hormone drospirenone are more likely to suffer severe side effects such as blood clots. These types of birth control include Bayer Pharmaceutical’s top-selling Yaz and Yasmin. More »
Korea restricts sales of Yaz and Yasmin due to blood clot risks
Korea will restrict sales of top-selling birth control pills Yaz and Yasmin in response to growing evidence that the drugs could increase the risk of fatal blood clots. Yaz and Yasmin will be restricted among women who are over 40, obese, suffer from headaches or other related conditions. More »
Family suspects Yaz may have contributed to daughter’s blood clot death
Top-selling birth control pill Yaz may have been a contributing factor in the death of a 25-year old woman, her family says. According to the mother of Shantinique Roberts, she was routinely taking the contraceptive before developing a blood clot which led to a fatal aneurysm. More »
Bayer to pay $110 million in Yasmin and Yaz lawsuit settlements
The manufacturer of Yaz and Yasmin will pay more than $110 million to settle nearly 500 lawsuits alleging that Yasmin caused blood clots in patients who used the drug. Bayer Pharmaceuticals is facing more than 11,000 Yasmin and Yaz lawsuits, according to a recent filing by the company. More »
FDA’s Yasmin and Yaz Blood Clots Warning is a Victory for Consumers, says Hissey Kientz, LLP
The Food and Drug Administration’s decision to strengthen warnings about the risk of blood clots from using Yaz and Yasmin is a victory for consumers, says the law firm of Hissey Kientz, LLP. On April 10, 2012, the FDA announced that it would add stronger warning labels to Yaz, Yasmin and similar birth control pills about the risk of blood clots these drugs can cause. More »
Yaz lawsuits link birth control pills to 50 deaths
The birth control drug Yaz has been linked to at least 50 deaths across the United States according to lawsuits filed against the manufacturer. These Yaz lawsuits allege that the birth control pills can increase the risk of fatal blood clots and other side effects, including heart attack, stroke, pulmonary embolism and deep vein thrombosis. More »
FDA panel members had ties to Yaz, Yasmin maker, government watchdog says
Members of the joint commission assembled to discuss the risks of Yaz and Yasmin had undisclosed ties to the pills’ manufacturer, a government watchdog has revealed. The Project On Government Oversight has asked the Food and Drug Administration to throw out the panel’s vote to keep Yaz and Yasmin on the market after it revealed that some of the members have worked closely with Bayer, the drug’s manufacturer. More »
Ortho Evra users who switch to Yaz or Yasmin may face side effects risk
Ortho Evra users who may have switched or are considering switching from the birth control patch to Yaz and Yasmin—or their generic equivalent, Ocella—may be surprised to learn of recent studies which have found an increased risk of blood clots compared to other birth control brands. Many Ortho Evra patients stopped using the patch after reports emerged that it could increase their risk of blood clots or other side effects. More »